Supreme Court Seems To Disfavor Vermont's Prescriber Data Mining Law
This article was originally published in The Pink Sheet Daily
Justices question the law's sole prohibition against use of the data for pharmaceutical marketing.
You may also be interested in...
Supreme Court To Address Prescriber Data, Free Speech And Pharma Marketing In Sorrell V. IMS
Does a Vermont law restricting the pharmaceutical industry's use of physician prescribing information violate the First Amendment? That's the question the Supreme Court will take up on April 26 when it hears oral arguments in Sorrell v. IMS Health Inc.
Data Mining Could End Up At Supreme Court After Second Circuit Ruling On Vermont Law
Appeals court says the state could pursue alternative measures to contain healthcare costs, such as academic detailing and mandating generic drugs for patients receiving Medicare Part D funds.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.